Literature DB >> 6788290

Pronounced cerebellar features in legionnaires' disease.

M R Maskill, E C Jordan.   

Abstract

Mesh:

Year:  1981        PMID: 6788290      PMCID: PMC1506381          DOI: 10.1136/bmj.283.6286.276

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  The compromised host and Legionnaires' disease.

Authors:  L D Saravolatz; K H Burch; E Fisher; T Madhavan; D Kiani; T Neblett; E L Quinn
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

2.  Clinical aspects of Legionnaires' disease.

Authors:  M N Swartz
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

3.  Legionnaires' disease in non-Legionnaires. A report of five cases.

Authors:  H M Friedman
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

4.  Legionnaires' disease in patients with associated serious disease.

Authors:  D W Gump; R O Frank; W C Winn; R S Foster; C V Broome; W B Cherry
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Legionnaires' disease with profound cerebellar involvement.

Authors:  K R Shetty; C L Cilyo; B D Starr; D H Harter
Journal:  Arch Neurol       Date:  1980-06
  5 in total
  4 in total

1.  Severe peripheral neuropathy complicating legionnaires' disease.

Authors:  D J Morgan; J Gawler
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

2.  Neurological involvement in legionellosis.

Authors:  A I Weir; I Bone; D H Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

3.  Cerebellar disturbance in psittacosis.

Authors:  C D Shee
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

4.  Legionella pneumophila infection presenting as headache, confusion and dysarthria in a human immunodeficiency virus-1 (HIV-1) positive patient: case report.

Authors:  Nathaniel M Robbins; Aditi Kumar; Barbra M Blair
Journal:  BMC Infect Dis       Date:  2012-09-22       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.